OAM
EVH icon

Oppenheimer Asset Management’s Evolent Health EVH Stock Holding History

Oppenheimer Asset Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-164,107
Closed -$891K – 1179
2020
Q1 		$891K Buy
164,107
+11,423
+7% +$102K 0.02% 586
2019
Q4 		$1.38M Sell
152,684
-10,312
-6% -$83.8K 0.03% 542
2019
Q3 		$1.17M Sell
162,996
-7,234
-4% -$51.9K 0.03% 566
2019
Q2 		$1.35M Buy
170,230
+257
+0.2% +$3.04K 0.03% 523
2019
Q1 		$2.14M Buy
169,973
+14,366
+9% +$227K 0.05% 389
2018
Q4 		$3.1M Buy
155,607
+21,233
+16% +$491K 0.08% 280
2018
Q3 		$3.82M Buy
134,374
+12,459
+10% +$297K 0.08% 273
2018
Q2 		$2.57M Buy
121,915
+51,975
+74% +$984K 0.06% 339
2018
Q1 		$996K Buy
69,940
+8,515
+14% +$122K 0.03% 600
2017
Q4 		$1.09M Hold
61,425
– – 0.03% 572
2017
Q3 		$1.09M Buy
61,425
+2,495
+4% +$51.4K 0.03% 575
2017
Q2 		$1.49M Buy
+58,930
New +$1.42M 0.04% 444

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Oppenheimer Asset Management's EVH Position: Q2 2020 in Review

Oppenheimer Asset Management sold out of Evolent Health (EVH) in Q2 2020, closing a stake of 164,107 shares — an estimated $891K sold.

Oppenheimer Asset Management first reported a position in EVH in Q2 2017 and held it in 12 quarters. The position peaked at $3.82M in Q3 2018. 136 funds tracked by Wall St. Rank hold EVH as of Q2 2020.

  • Oppenheimer Asset Management reported no remaining Evolent Health position as of Q2 2020 after selling out during the quarter.
  • Oppenheimer Asset Management sold 164,107 Evolent Health shares in Q2 2020, an estimated $891K.
  • Oppenheimer Asset Management first reported a position in Evolent Health in Q2 2017 and held it in 12 quarters.
  • Oppenheimer Asset Management's Evolent Health position peaked at $3.82M in Q3 2018.
  • 136 funds tracked by Wall St. Rank held Evolent Health as of Q2 2020.

Based on Oppenheimer Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.